Zhitong Finance App News, Eling Pharmaceutical (002603.SZ) issued an announcement. Recently, the company received the “Notice of Acceptance” approved and issued by the State Drug Administration. The name of the drug is “LB220-D08 sustained-release tablets”.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.